Cargando…
Blocking type TSH receptor antibodies
TSH receptor (TSHR) autoantibodies (TRAbs) play a key role in the pathogenesis of Graves’ disease. In the majority of patients, TRAbs stimulate thyroid hormone synthesis via activation of the TSHR (stimulating TRAbs, TSHR agonists). In some patients, TRAbs bind to the receptor but do not cause activ...
Autores principales: | Furmaniak, Jadwiga, Sanders, Jane, Rees Smith, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389084/ https://www.ncbi.nlm.nih.gov/pubmed/26000138 http://dx.doi.org/10.1007/s13317-012-0028-1 |
Ejemplares similares
-
Structure and activation of the TSH receptor transmembrane domain
por: Núñez Miguel, Ricardo, et al.
Publicado: (2016) -
TSH receptor specific monoclonal autoantibody K1‐70(TM) targeting of the TSH receptor in subjects with Graves' disease and Graves' orbitopathy—Results from a phase I clinical trial
por: Furmaniak, Jadwiga, et al.
Publicado: (2022) -
Preclinical studies on the toxicology, pharmacokinetics and safety of K1-70(TM) a human monoclonal autoantibody to the TSH receptor with TSH antagonist activity
por: Furmaniak, Jadwiga, et al.
Publicado: (2019) -
Structure of full-length TSH receptor in complex with antibody K1-70™
por: Núñez Miguel, Ricardo, et al.
Publicado: (2022) -
Practical applications of studies on the TSH receptor and TSH receptor autoantibodies
por: Furmaniak, J., et al.
Publicado: (2020)